Delving into the Latest Updates on HYNRCS-Allo(Corestem) with Synapse

Overview

Basic Info

Drug Type

Stem cell therapy

Synonyms

HYNR-CS-Allo Inj

Target-

Action-

Mechanism

Cell replacements

Therapeutic Areas

Nervous System DiseasesEndocrinology and Metabolic DiseaseOther Diseases

Active Indication-

Inactive Indication

Amyotrophic Lateral Sclerosis

Originator Organization

CORESTEMCHEMON, Inc.

Active Organization-

Inactive Organization

CORESTEMCHEMON, Inc.

Hanyang University

License Organization-

Drug Highest PhasePendingPhase 1

First Approval Date-

Regulation-

Login to view timeline

The purpose of this study is to evaluate the safety and efficacy of HLA-haplo matched Allogenic Bone Marrow Derived stem cells("HYNRCS-Allo-ALS-02 inj"), through intrathecal delivery for the repeated treatment after 6 months of first treatment in patients with amyotrophic lateral sclerosis(ALS).
This study is an open label, single-dose study to assess the safety and efficacy of HLA-haplo matched Allogenic Bone Marrow Derived stem cells("HYNRCS-Allo-ALS-02 inj")

Start Date01 Feb 2017

Sponsor / Collaborator

CORESTEMCHEMON, Inc.

NCT01758510

/ CompletedPhase 1IIT

An Open-label, Phase 1 Trial for Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell("HYNR-CS-Allo Inj") Treatment in Amyotrophic Lateral Sclerosis(ALS)

The purpose of this study is to evaluate the safety of HLA-haplo matched Allogenic Bone Marrow Derived stem cells("HYNR-CS-Allo inj"), through intrathecal delivery for the treatment in patients with amyotrophic lateral sclerosis(ALS).
This study is an open label, dose up and down study using the 3+3 design to assess the safety of HLA-haplo matched Allogenic Bone Marrow Derived stem cells("HYNR-CS-Allo inj")

Start Date01 Dec 2012

Sponsor / Collaborator

CORESTEMCHEMON, Inc.

100 Clinical Results associated with HYNRCS-Allo(Corestem)

Login to view more data

100 Translational Medicine associated with HYNRCS-Allo(Corestem)

Login to view more data

100 Patents (Medical) associated with HYNRCS-Allo(Corestem)

Login to view more data

100 Deals associated with HYNRCS-Allo(Corestem)

Login to view more data